Advertisement
UK markets close in 1 hour 35 minutes
  • FTSE 100

    7,851.01
    -26.04 (-0.33%)
     
  • FTSE 250

    19,330.65
    -120.02 (-0.62%)
     
  • AIM

    743.46
    -1.83 (-0.25%)
     
  • GBP/EUR

    1.1678
    -0.0005 (-0.04%)
     
  • GBP/USD

    1.2459
    +0.0021 (+0.17%)
     
  • Bitcoin GBP

    52,055.50
    +1,956.81 (+3.91%)
     
  • CMC Crypto 200

    1,331.23
    +18.61 (+1.44%)
     
  • S&P 500

    5,013.60
    +2.48 (+0.05%)
     
  • DOW

    37,953.01
    +177.63 (+0.47%)
     
  • CRUDE OIL

    82.73
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,399.80
    +1.80 (+0.08%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,735.09
    -102.31 (-0.57%)
     
  • CAC 40

    8,022.01
    -1.25 (-0.02%)
     

3 Top Pot Stocks to Watch in December

3 Top Pot Stocks to Watch in December

With marijuana regulations on the ballot, major players in the industry making big changes to their strategies, and many companies struggling to grow their sales, there's a whirlpool containing both danger and opportunity for investors. Since its announcement in late October that it would enter the U.S. cannabis market faster than previously planned, Canopy Growth's (NASDAQ: CGC) shares are up by around 45%, and there might be more to come. The cannabis cultivator's pivot to focus on the U.S. comes at a time when it's selling off its Canadian retail outlets, meaning that the Canopy Growth of 2023 and beyond will look little like what investors are accustomed to.